Group purchasing organizations Novation and Premier inked 8 new supply contracts for OR integration and automation systems, dialysis equipment and patient monitoring equipment.
Steris Corp. (NYSE:STE) customers have an extra 6 months from the FDA to transition from the company’s recalled System 1 sterilization device.
The med-tech maker will support current System 1 devices until August 2, 2012 but only in companies that provide a certificate of transition identifying the proposed installation date of replacement technology, according to an SEC filing.
Sterilization and decontamination technology firm Steris Corp. (NYSE:STE) opened a new European headquarters in Bordeaux, France.
In the 85,000 square-foot facility, Steris combined marketing, manufacturing, sales, costumer service and research & development.
Steris Corp. (NYSE:STE) and Toshiba Medical Systems Corp. struck a deal to collaborate on creating hybrid operating room suites.
The hybrid suites allow surgical and diagnostic teams to perform open surgeries and carry out a wide range of image-guided cardiovascular, vascular and neurosurgical procedures without moving a patient from room to room.
Shares of Becton Dickinson (NYSE:BDX) slipped 4.4 percent today after the company announced a 24.4 percent profit slide and missed Wall Street’s expectations for its Q4 earnings.
BD posted profits of $300.0 million, or $1.36 per share, on sales of $2.05 billion for the three months ended Sept. 30. That compares with profits of $396.7 million, or $1.68 per share, on sales of $1.87 billion during the same period last year.
Masimo Corp. (NDSQ:MASI) landed clearance in the U.S. and Europe for its Radical-7 non-invasive pulse oximeter with rainbow acoustic monitoring technology.
The Irvine, Calif.-based company’s system provides doctors with continuous readings of acoustic respiration rate waveform and measurements.
Masimo added a new feature called In Vivo Adjustment, not yet approved by the FDA that allows doctors to account for individual patient biases and adjust the device to readings from invasive blood analysis devices.
Medical device makers dropped at least $623,250 on the 2011-2012 election cycle, according to a MassDevice examination of a federal database that tracks corporate donations to legislators and political actions committees, known as PACs.
Abbott Laboratories (NYSE:ABT) alone accounted for more than 45 percent of the donations, spending a total of $282,000 — nearly $100,000 to individual members of Congress and the rest to various PACs, according to the Federal Election Commission’s online database.
The Food & Drug Administration gave Steris Corp. (NYSE:STE) customers an additional six months to transition from the company’s recalled System 1 sterilization device.
The agency gave the Mentor, Ohio-based company’s customers until Feb. 2, 2012 to make the change to an alternate processing system, according to a filing with the Securities & Exchange Commission.
Sterilization and decontamination technology firm Steris Corp. (NYSE:STE) says construction on a new $11 million, 55,000-square-foot customer solutions center in suburban Cleveland is expected to wrap up in May.
Steris employees are scheduled to begin moving in around that time and hosting customers in early summer, spokesman Steve Norton said.
During the cold winter months, workers focused on the interior of the building, but as the weather warms up, they’ll shift their emphasis to the building’s exterior, Norton said.
Another lawsuit was added to the avalanche of litigation that DePuy Orthopaedics Inc. is facing over one of its hip implants, after a Tennessee woman sued the company over an allegedly faulty hip implant.
Kathern Hensley was implanted with a DePuy ASR XL Acetabular hip replacement system, according to a statement from the law firms representing the plaintiff.